Association between familial atrial fibrillation and risk of new-onset atrial fibrillation
- PMID: 21076174
- PMCID: PMC3073054
- DOI: 10.1001/jama.2010.1690
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation
Abstract
Context: Although the heritability of atrial fibrillation (AF) is established, the contribution of familial AF to predicting new-onset AF remains unknown.
Objective: To determine whether familial occurrence of AF is associated with new-onset AF beyond established risk factors.
Design, setting, and participants: The Framingham Heart Study, a prospective community-based cohort study started in 1948. Original and Offspring Cohort participants were aged at least 30 years, were free of AF at the baseline examination, and had at least 1 parent or sibling enrolled in the study. The 4421 participants in this analysis (mean age, 54 [SD, 13] years; 54% women) were followed up through December 31, 2007.
Main outcome measures: Incremental predictive value of incorporating different features of familial AF (any familial AF, premature familial AF [onset ≤65 years old], number of affected relatives, and youngest age of onset in a relative) into a risk model for new-onset AF.
Results: Across 11,971 examinations during the period 1968-2007, 440 participants developed AF. Familial AF occurred among 1185 participants (26.8%) and premature familial AF occurred among 351 participants (7.9%). Atrial fibrillation occurred more frequently among participants with familial AF than without familial AF (unadjusted absolute event rates of 5.8% and 3.1%, respectively). The association was not attenuated by adjustment for AF risk factors (multivariable-adjusted hazard ratio, 1.40; 95% confidence interval [CI], 1.13-1.74) or reported AF-related genetic variants. Among the different features of familial AF examined, premature familial AF was associated with improved discrimination beyond traditional risk factors to the greatest extent (traditional risk factors, C statistic, 0.842 [95% CI, 0.826-0.858]; premature familial AF, C statistic, 0.846 [95% CI, 0.831-0.862]; P = .004). Modest changes in integrated discrimination improvement were observed with premature familial AF (2.1%). Net reclassification improvement (assessed using 8-year risk thresholds of <5%, 5%-10%, and >10%) did not change significantly with premature familial AF (index statistic, 0.011; 95% CI, -0.021 to 0.042; P = .51), although categoryless net reclassification was improved (index statistic, 0.127; 95% CI, 0.064-0.189; P = .009).
Conclusions: In this cohort, familial AF was associated with an increased risk of AF that was not attenuated by adjustment for AF risk factors including genetic variants. Assessment of premature familial AF was associated with a very slight increase in predictive accuracy compared with traditional risk factors.
Figures
Similar articles
-
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.JAMA. 2004 Jun 16;291(23):2851-5. doi: 10.1001/jama.291.23.2851. JAMA. 2004. PMID: 15199036
-
Association Between Family History and Early-Onset Atrial Fibrillation Across Racial and Ethnic Groups.JAMA Netw Open. 2018 Sep 7;1(5):e182497. doi: 10.1001/jamanetworkopen.2018.2497. JAMA Netw Open. 2018. PMID: 30646169 Free PMC article.
-
Obesity and the risk of new-onset atrial fibrillation.JAMA. 2004 Nov 24;292(20):2471-7. doi: 10.1001/jama.292.20.2471. JAMA. 2004. PMID: 15562125
-
Early menopause is associated with increased risk of heart failure and atrial fibrillation: A systematic review and meta-analysis.Maturitas. 2023 Oct;176:107784. doi: 10.1016/j.maturitas.2023.107784. Epub 2023 Jun 7. Maturitas. 2023. PMID: 37454569 Review.
-
Leucocyte telomere length and paroxysmal atrial fibrillation: A prospective cohort study and systematic review with meta-analysis.J Clin Lab Anal. 2018 Nov;32(9):e22599. doi: 10.1002/jcla.22599. Epub 2018 Jun 26. J Clin Lab Anal. 2018. PMID: 29943516 Free PMC article. Review.
Cited by
-
Identification of common mechanisms and biomarkers of atrial fibrillation and heart failure based on machine learning.ESC Heart Fail. 2024 Aug;11(4):2323-2333. doi: 10.1002/ehf2.14799. Epub 2024 Apr 24. ESC Heart Fail. 2024. PMID: 38656659 Free PMC article.
-
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.J Interv Card Electrophysiol. 2024 Aug;67(5):921-1072. doi: 10.1007/s10840-024-01771-5. J Interv Card Electrophysiol. 2024. PMID: 38609733 Review.
-
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace. 2024 Mar 30;26(4):euae043. doi: 10.1093/europace/euae043. Europace. 2024. PMID: 38587017 Free PMC article.
-
Identification and validation of potential biomarkers for atrial fibrillation based on integrated bioinformatics analysis.Front Cell Dev Biol. 2024 Jan 11;11:1190273. doi: 10.3389/fcell.2023.1190273. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38274270 Free PMC article.
-
A Discussion of the Contemporary Prediction Models for Atrial Fibrillation.Med Res Arch. 2023 Oct;11(10):4481. doi: 10.18103/mra.v11i10.4481. Epub 2023 Oct 25. Med Res Arch. 2023. PMID: 38050581 Free PMC article.
References
-
- Fox CS, Parise H, D’Agostino RB, Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 2004 Jun 16;291(23):2851–2855. - PubMed
-
- Arnar DO, Thorvaldsson S, Manolio TA, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J. 2006 Mar;27(6):708–712. - PubMed
-
- Darbar D, Herron KJ, Ballew JD, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol. 2003 Jun 18;41(12):2185–2192. - PubMed
-
- Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet. 2005 Nov;118(2):179–184. - PubMed
Publication types
MeSH terms
Grants and funding
- Z01 HL001056/Intramural NIH HHS/United States
- RC1-HL01056/HL/NHLBI NIH HHS/United States
- R21 DA027021/DA/NIDA NIH HHS/United States
- R01 HL104156/HL/NHLBI NIH HHS/United States
- T32 HL007575/HL/NHLBI NIH HHS/United States
- L30 HL097675/HL/NHLBI NIH HHS/United States
- R01 HL102214/HL/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
- 6R01-NS17950/NS/NINDS NIH HHS/United States
- HL092577/HL/NHLBI NIH HHS/United States
- HL104156/HL/NHLBI NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- R01AG028321/AG/NIA NIH HHS/United States
- DA027021/DA/NIDA NIH HHS/United States
- T32HL007575/HL/NHLBI NIH HHS/United States
- T32 HL007575-27/HL/NHLBI NIH HHS/United States
- 1R01HL102214/HL/NHLBI NIH HHS/United States